GLS-010

· Guangzhou Gloria Biosciences Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for GLS-010, covering 2019-06-05 to 2023-08-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]

See pricing